This analysis used data from 3,390 adults enrolled in the CHASING COVID Cohort who completed assessments in August 2025 and again in March 2026. The investigators defined vaccine willingness using a combination of prior-season vaccination and stated intention to vaccinate during the 2025–26 respiratory virus season. Actual vaccine uptake was measured by self-reported vaccination status by March 2026 for both influenza and COVID-19 vaccines. The report is a preprint and has not undergone peer review.
In August 2025, a majority of participants expressed willingness to be vaccinated: 73% for influenza and 68% for COVID-19. Despite this stated willingness, a substantial proportion remained unvaccinated by March 2026. Among those classified as vaccine-willing, 17% had not received the influenza vaccine and 39% had not received a COVID-19 vaccine by the follow-up assessment. These figures highlight a measurable gap between intention and completion of vaccination during the 2025–26 respiratory virus season.
The strongest predictor of not vaccinating—despite prior expressed willingness—was absence of vaccination in the prior season. For influenza, absence of prior-season vaccination was associated with an adjusted risk ratio (aRR) of 4.04 (95% CI 3.44–4.74). For COVID-19, the aRR was 3.01 (95% CI 2.72–3.34).
Other independent predictors of remaining unvaccinated included: food insecurity (influenza aRR 1.99; COVID-19 aRR 1.47), reporting any healthcare barrier (influenza aRR 1.89; COVID-19 aRR 1.51), and being not at all confident in vaccine safety (influenza aRR 2.95; COVID-19 aRR 2.21). These results point to both structural and attitudinal determinants of vaccine completion among people who are not outright opposed to vaccination.
Trajectory analyses reported in the study suggested that the observed willingness-to-uptake gaps were driven by two main patterns: incomplete follow-through on stated intentions during the season and discontinuation among individuals who had previously vaccinated in prior seasons. In other words, the gap was not solely due to initial hesitancy but also reflected failures to act on intentions and loss of continuity in routine vaccination behaviors.
Among participants who were classified as vaccine-willing but remained unvaccinated, commonly reported reasons included difficulty finding a convenient time, place, or appointment to receive the vaccine. For COVID-19 specifically, an additional commonly reported reason was lack of a healthcare provider recommendation. These self-reported barriers point to logistical and healthcare system factors that inhibited vaccination even among those open to receiving vaccines.
The findings emphasize missed opportunities to convert vaccine willingness into completed vaccination. Potential programmatic responses suggested by the pattern of results include strategies to: reinforce vaccine confidence among those uncertain about safety; reduce access barriers such as appointment availability and convenience; address socioeconomic obstacles including food insecurity that correlate with non-vaccination; and ensure proactive provider recommendations, particularly for COVID-19 vaccination. Interventions that simplify the final steps of vaccination—making it easier to complete—are highlighted as potentially effective for increasing coverage.
This report is a preprint and the findings have not been peer reviewed. The analysis used self-reported vaccination and intention measures from the CHASING COVID Cohort; further methodological details beyond those summarized here were not reported in the abstract. The authors declare that the CUNY School of Public Health received research support from Pfizer during the conduct of the study, paid directly to CUNY, with Dr. Nash listed as Principal Investigator. Additional funders included the Schmidt Family Foundation and the CUNY Institute for Implementation Science in Population Health. Ethical approval was provided by the Institutional Review Board at the CUNY Graduate School for Public Health and Health Policy.
Notes: All specific values and associations reported here are taken from the source preprint abstract. The preprint cautions that results have not yet been certified by peer review and should not be used to guide clinical practice without further validation.